Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

NCT07619547 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT07619547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07619547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Observational
Overall status
Recruiting
Start date
October 19, 2026
Completion date
June 1, 2036
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel disease, ulcerative colitis